Hypertransfusion

therapeutic regimen aiming to attain a pre-transfusional level of hemoglobin of 9 to 10.5 g/dL in thalassemic patents

Description
Hypertransfusion is not to be confused with other regimens, such as the supertransfusion, which aim at much higher pre-transfusional hemoglobin levels, or other less, intense transfusion regimens, which leave the patients with much lower hemoglobin values (less than 9g/dL before each new transfusion). A hypertransfusion regimen is believed to be the most beneficial transfusion regimen to thalassemic patients in general (although there are exception, depending on the genetic background), as it offers the best compromise between treating the anemia and input of excess iron.